Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Mitochondrial enzyme deficits may mark energy impairment in hypertensive hypertrophy; leaves open human relevance and therapeutic targeting.
Tokoro et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: